Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107099516A details high-efficiency enzymatic UDCA production. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105566257B details a scalable route for acetyl tetrahydrofuran. This process ensures high optical purity and significant cost reduction in API intermediate manufacturing.
Advanced synthesis of indazole-triazole compounds via click chemistry for Bcr-Abl inhibition. Reliable pharma intermediate supplier offering cost-effective scale-up.
Patent CN110105355A reveals efficient one-pot synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN117700340B reveals homogeneous catalytic route for Iguratimod intermediate. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN102844314B details efficient Passerini reaction routes for protease inhibitors. Offers high purity pharmaceutical intermediates with streamlined synthesis and significant supply chain advantages for global partners.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.
Patent CN1265650A reveals a novel double-protection strategy for synthesizing 6-amino-3-azabicyclo[3.1.0]hexane derivatives, offering superior stereoselectivity and cost-effective routes for quinolone antibiotic manufacturing.
Patent CN102304095B details a novel 5-step synthesis for Sulfadoxine, eliminating toxic catalysts and improving purity for cost-effective pharmaceutical manufacturing.
Patent CN113200948A reveals a cost-effective copper-catalyzed route for chiral phthalides, offering high enantioselectivity and supply chain advantages for pharmaceutical manufacturers.
Patent CN1106395C details a novel asymmetric synthesis for IBAT inhibitor intermediates, offering superior stereocontrol and scalable manufacturing for pharmaceutical supply chains.
Patent CN106701698A reveals high-efficiency enzymatic synthesis for chiral alcohols. Offers cost reduction and high purity for pharmaceutical supply chains.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Patent CN107814824A reveals a noble-metal-free route for steroid intermediates. This ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Novel Strecker reaction route for Clopidogrel bisulfate. High yield, scalable process for pharmaceutical intermediates manufacturing.
Patent CN108358847B reveals a metal-free route for imidazolin-2-one compounds. This method offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1399632A details a safer route for pyrimidine derivatives, eliminating hazardous Curtius rearrangement for reliable pharmaceutical intermediate supply.
Patent CN119119036A reveals catalyst-free pyridinium synthesis. Offers cost reduction in pharmaceutical manufacturing and high-purity intermediate supply chain reliability.
Novel PTC-catalyzed oxidation of 3,5-lutidine yields high-purity 5-methylnicotinic acid. Reduces water usage and boosts efficiency for Rupatadine manufacturing.